|Datasheet||Specific References||Reviews||Related Products||Protocols|
|Vector Type||Mammalian Expression Vector|
|Expression Method||Constiutive ,Stable / Transient|
|Selection In Mammalian Cells||Hygromycin|
A myc tag is a polypeptide protein tag derived from the c-myc gene product that can be added to a protein using recombinant DNA technology. It can be used for affinity chromatography, then used to separate recombinant, overexpressed protein from wild type protein expressed by the host organism. It can also be used in the isolation of protein complexes with multiple subunits.
A myc tag can be used in many different assays that require recognition by an antibody. If there is no antibody against the studied protein, adding a myc-tag allows one to follow the protein with an antibody against the Myc epitope. Examples are cellular localization studies by immunofluorescence or detection by Western blotting.
The peptide sequence of the myc-tag is: N-EQKLISEEDL-C (1202 Da). It can be fused to the C-terminus and the N-terminus of a protein. It is advisable not to fuse the tag directly behind the signal peptide of a secretory protein, since it can interfere with translocation into the secretory pathway.
|Mouse IL1RN ORF mammalian expression plasmid, C-GFPSpark tag||MG51300-ACG|
|Mouse IL1RN ORF mammalian expression plasmid, C-OFPSpark / RFP tag||MG51300-ACR|
|Mouse IL1RN ORF mammalian expression plasmid, C-Flag tag||MG51300-CF|
|Mouse IL1RN ORF mammalian expression plasmid, C-His tag||MG51300-CH|
|Mouse IL1RN ORF mammalian expression plasmid, C-Myc tag||MG51300-CM|
|Mouse IL1RN ORF mammalian expression plasmid, C-HA tag||MG51300-CY|
|Mouse IL1RN Gene cDNA clone plasmid||MG51300-G|
|Mouse IL1RN ORF mammalian expression plasmid, N-Flag tag||MG51300-NF|
|Mouse IL1RN ORF mammalian expression plasmid, N-His tag||MG51300-NH|
|Mouse IL1RN ORF mammalian expression plasmid, N-Myc tag||MG51300-NM|
|Mouse IL1RN ORF mammalian expression plasmid, N-HA tag||MG51300-NY|
|Mouse IL1RN natural ORF mammalian expression plasmid||MG51300-UT|
|Learn more about expression Vectors|
Interleukin-1 receptor antagonist (IL-1RA) also known as IL1RN is a member of the interleukin 1 cytokine family. This protein inhibits the activities of interleukin 1, alpha (IL1A) and interleukin 1, beta (IL1B), and modulates a variety of interleukin 1 related immune and inflammatory responses. A polymorphism of this protein encoding gene is reported to be associated with increased risk of osteoporotic fractures and gastric cancer. IL-1RA/IL1RN may inhibit the activity of IL-1 by binding to its receptor and it has no IL-1 like activity. Genetic variation in IL-1RA/IL1RN is associated with susceptibility to microvascular complications of diabetes type 4 (MVCD4). These are pathological conditions that develop in numerous tissues and organs as a consequence of diabetes mellitus. They include diabetic retinopathy, diabetic nephropathy leading to end-stage renal disease, and diabetic neuropathy. Diabetic retinopathy remains the major cause of new-onset blindness among diabetic adults. It is characterized by vascular permeability and increased tissue ischemia and angiogenesis. Defects in IL-1RA/IL1RN are the cause of interleukin 1 receptor antagonist deficiency (DIRA) which is also known as deficiency of interleukin 1 receptor antagonist. Autoinflammatory diseases manifest inflammation without evidence of infection, high-titer autoantibodies, or autoreactive T-cells. DIRA is a rare, autosomal recessive, genetic autoinflammatory disease that results in sterile multifocal osteomyelitis, and pustulosis from birth.